In case of Beckwith-Wiedemann syndrome, demethylation of the IGF2/H19 imprinting control region leads to the binding of CTCF and subsequently blocks the connection between an enhancer for IGF2 and promotes activation of maternal H19 [198]. The gene discussed is H19; the disease is Beckwith-Wiedemann syndrome.